Skip to main content

Table 5 Comparison of overall incidence (/100,000) between target and calibration

From: Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria

 

4-valent vaccination

9-valent vaccination

 

Target

Calibration results

Target

Calibration results

Female

Incidence

    

 Cervical cancer

6.12

6.12

7.48

7.48

 CIN 2+

63.15

22.29

114.23

27.62

 Vaginal

0.56

0.05

0.67

0.05

 Vulvar

0.44

0.08

0.50

0.08

 Anal

1.37

1.37

1.42

1.42

 Genital warts

127.08

126.93

127.08

126.93

 Head and Neck

0.96

0.96

0.96

0.96

Mortality

    

 Cervical cancer

2.98

2.98

3.65

3.65

 Vaginal

0.20

0.02

0.10

0.02

 Vulvar

0.90

0.03

0.15

0.03

 Anal

0.23

0.23

0.24

0.24

Male

Incidence

    

 Penile cancer

0.41

0.41

0.41

0.41

 Anal cancer

0.76

0.76

0.79

0.79

 Genital warts

131.85

131.52

131.85

131.52

 Head and Neck

4.23

4.25

4.23

4.25

Mortality

    

 Penile cancer

0.10

0.10

0.10

0.10

 Anal cancer

0.23

0.22

0.24

0.23